136 related articles for article (PubMed ID: 21335945)
1. Long-term survival in a patient with node-positive adult-onset Xp11.2 translocation renal cell carcinoma.
Aoyagi T; Shinohara N; Kubota-Chikai K; Kuroda N; Nonomura K
Urol Int; 2011; 86(4):487-90. PubMed ID: 21335945
[TBL] [Abstract][Full Text] [Related]
2. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
3. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.
Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I
Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722
[TBL] [Abstract][Full Text] [Related]
4. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
5. Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.
Liu N; Wang Z; Gan W; Xiong L; Miao B; Chen X; Guo H; Li D
PLoS One; 2016; 11(11):e0166897. PubMed ID: 27893792
[TBL] [Abstract][Full Text] [Related]
6. An adult case of melanotic Xp11 translocation renal cancers: distinct entity or sub-entity?
Varinot J; Camparo P; Beurtheret S; Barreda E; Compérat E
Int J Surg Pathol; 2011 Jun; 19(3):285-9. PubMed ID: 21427096
[TBL] [Abstract][Full Text] [Related]
7. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
8. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C
Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350
[TBL] [Abstract][Full Text] [Related]
9. Xp11.2 translocation renal carcinoma with placental metastasis: a case report.
Bovio IM; Allan RW; Oliai BR; Hampton T; Rush DS
Int J Surg Pathol; 2011 Feb; 19(1):80-3. PubMed ID: 19164407
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
J Urol; 2008 Jul; 180(1):99-103; discussion 103. PubMed ID: 18485415
[TBL] [Abstract][Full Text] [Related]
11. [Research advances in Xp11.2 translocation renal cell carcinoma].
Huang JH; Zhou FJ
Ai Zheng; 2008 Sep; 27(9):1006-8. PubMed ID: 18799045
[TBL] [Abstract][Full Text] [Related]
12. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
13. [A case of xp11.2 translocation renal cell carcinoma].
Horie K; Kikuchi M; Miwa K; Minamidate Y; Yokoi S; Nakano M; Deguchi T; Ehara H; Asano N; Hirose Y
Hinyokika Kiyo; 2011 Mar; 57(3):129-33. PubMed ID: 21586884
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma with Xp11.2 translocation in a 7-year-old boy.
Jayasinghe C; Siegler N; Leuschner I; Fleischhack G; Born M; Müller AM
Klin Padiatr; 2010 May; 222(3):187-9. PubMed ID: 20514625
[TBL] [Abstract][Full Text] [Related]
16. Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features.
Suzigan S; Drut R; Faria P; Argani P; De Marzo AM; Barbosa RN; Mello Denadai ER; Martins-Filho J; Martucci RC; Bauab T
Int J Surg Pathol; 2007 Apr; 15(2):199-203. PubMed ID: 17478783
[TBL] [Abstract][Full Text] [Related]
17. Xp11 translocation renal cell carcinoma morphologically mimicking clear cell-papillary renal cell carcinoma in an adult patient: report of a case expanding the morphologic spectrum of Xp11 translocation renal cell carcinomas.
Parihar A; Tickoo SK; Kumar S; Arora VK
Int J Surg Pathol; 2015 May; 23(3):234-7. PubMed ID: 25519951
[TBL] [Abstract][Full Text] [Related]
18. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of Xp11.2 translocation renal cell carcinoma.
Lim B; You D; Jeong IG; Kwon T; Hong S; Song C; Cho YM; Hong B; Hong JH; Ahn H; Kim CS
Korean J Urol; 2015 Mar; 56(3):212-7. PubMed ID: 25763125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
